Kezar Historical Income Statement
| KZR Stock | USD 5.13 0.04 0.77% |
Historical analysis of Kezar Life income statement accounts such as Interest Expense of 1.7 M can show how well Kezar Life Sciences performed in making a profits. Evaluating Kezar Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Kezar Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Kezar Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kezar Life Sciences is a good buy for the upcoming year.
Kezar |
About Kezar Income Statement Analysis
Kezar Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Kezar Life shareholders. The income statement also shows Kezar investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Kezar Life Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Kezar Life Sciences. It is also known as Kezar Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Kezar Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Kezar Life's Net Interest Income is relatively stable compared to the past year. As of 03/27/2025, Interest Income is likely to grow to about 8.9 M, while Selling General Administrative is likely to drop slightly above 14.5 M.
Kezar Life income statement Correlations
Click cells to compare fundamentals
Kezar Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kezar Life income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Interest Income | 1.2M | 29K | 2.9M | 9.1M | 6.9M | 7.2M | |
| Interest Income | 1.2M | 188K | 4.1M | 10.6M | 8.5M | 8.9M | |
| Depreciation And Amortization | 1.5M | 1.5M | 1.0M | 1.1M | 1.2M | 1.0M | |
| Interest Expense | 1.2M | 159K | 1.2M | 1.6M | 1.6M | 1.7M | |
| Selling General Administrative | 12.0M | 15.7M | 20.2M | 26.5M | 23.4M | 14.5M | |
| Gross Profit | (1.5M) | (1.5M) | (1.0M) | 5.9M | 6.8M | 7.2M | |
| Other Operating Expenses | 43.0M | 54.7M | 71.2M | 112.2M | 129.1M | 135.5M | |
| Operating Income | (43.0M) | (54.7M) | (71.2M) | (105.2M) | (89.1M) | (84.7M) | |
| Net Income From Continuing Ops | (41.7M) | (54.6M) | (68.2M) | (87.8M) | (83.7M) | (79.5M) | |
| Ebit | (43.0M) | (54.5M) | (71.2M) | (100.3M) | (90.3M) | (85.8M) | |
| Research Development | 31.0M | 38.9M | 51.0M | 85.7M | 65.7M | 40.5M | |
| Ebitda | (41.4M) | (53.0M) | (70.1M) | (99.3M) | (89.3M) | (84.9M) | |
| Cost Of Revenue | 1.5M | 1.5M | 1.0M | 1.1M | 1.2M | 886.1K | |
| Total Operating Expenses | 43.0M | 54.7M | 71.2M | 118.4M | 89.1M | 55.8M | |
| Income Before Tax | (41.7M) | (54.6M) | (68.2M) | (101.9M) | (83.7M) | (79.5M) | |
| Total Other Income Expense Net | 1.2M | 29K | 2.9M | 3.4M | (1.5M) | (1.4M) | |
| Net Income Applicable To Common Shares | (35.1M) | (41.7M) | (54.6M) | (68.2M) | (61.4M) | (58.3M) | |
| Net Income | (39.0M) | (53.3M) | (65.3M) | (101.9M) | (83.7M) | (79.5M) | |
| Income Tax Expense | (2.8M) | (1.4M) | (2.9M) | 898.1K | 808.3K | 848.7K | |
| Reconciled Depreciation | 1.5M | 1.5M | 1.0M | 503K | 1.0M | 1.1M |
Pair Trading with Kezar Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Kezar Stock
Moving against Kezar Stock
| 0.8 | WM | Waste Management | PairCorr |
| 0.79 | LUCD | Lucid Diagnostics | PairCorr |
| 0.66 | GE | GE Aerospace | PairCorr |
| 0.47 | PLX | Protalix Biotherapeutics | PairCorr |
| 0.43 | PG | Procter Gamble | PairCorr |
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.